Reduction in Unnecessary Red Blood Cell Folate Testing by Restricting Computerized Physician Order Entry in the Electronic Health Record

2018 ◽  
Vol 131 (8) ◽  
pp. 939-944 ◽  
Author(s):  
Thomas E. MacMillan ◽  
Patrick Gudgeon ◽  
Paul M. Yip ◽  
Rodrigo B. Cavalcanti
2011 ◽  
Vol 7 (4) ◽  
pp. 233-237 ◽  
Author(s):  
Cara A. Harshberger ◽  
Abigail J. Harper ◽  
George W. Carro ◽  
Wayne E. Spath ◽  
Wendy C. Hui ◽  
...  

EHR/CPOE systems improve completeness of medical record and chemotherapy order documentation, as well as user satisfaction with the medical record system.


2017 ◽  
Vol 24 (2) ◽  
pp. 268-274 ◽  
Author(s):  
Juan D Chaparro ◽  
David C Classen ◽  
Melissa Danforth ◽  
David C Stockwell ◽  
Christopher A Longhurst

Objective: To evaluate the safety of computerized physician order entry (CPOE) and associated clinical decision support (CDS) systems in electronic health record (EHR) systems at pediatric inpatient facilities in the US using the Leapfrog Group’s pediatric CPOE evaluation tool. Methods: The Leapfrog pediatric CPOE evaluation tool, a previously validated tool to assess the ability of a CPOE system to identify orders that could potentially lead to patient harm, was used to evaluate 41 pediatric hospitals over a 2-year period. Evaluation of the last available test for each institution was performed, assessing performance overall as well as by decision support category (eg, drug-drug, dosing limits). Longitudinal analysis of test performance was also carried out to assess the impact of testing and the overall trend of CPOE performance in pediatric hospitals. Results: Pediatric CPOE systems were able to identify 62% of potential medication errors in the test scenarios, but ranged widely from 23–91% in the institutions tested. The highest scoring categories included drug-allergy interactions, dosing limits (both daily and cumulative), and inappropriate routes of administration. We found that hospitals with longer periods since their CPOE implementation did not have better scores upon initial testing, but after initial testing there was a consistent improvement in testing scores of 4 percentage points per year. Conclusions: Pediatric computerized physician order entry (CPOE) systems on average are able to intercept a majority of potential medication errors, but vary widely among implementations. Prospective and repeated testing using the Leapfrog Group’s evaluation tool is associated with improved ability to intercept potential medication errors.


2020 ◽  
Vol 3 (11) ◽  
pp. e2019652
Author(s):  
Hojjat Salmasian ◽  
Bonnie B. Blanchfield ◽  
Kelley Joyce ◽  
Kaila Centeio ◽  
Gordon B. Schiff ◽  
...  

2013 ◽  
Vol 48 (7) ◽  
pp. 568-573 ◽  
Author(s):  
Ryan Rodriguez ◽  
Benjamin Staley ◽  
Randy C. Hatton

Background Incorporation of drug restriction policy into electronic drug order entries (DOEs) can promote responsible medication use and resource utilization when implemented systematically. Objective To identify drugs that require further incorporation of formulary restriction policy into their DOEs after migration to an electronic health record with computerized prescriber order entry (CPOE). Methods After transition to CPOE, test orders for formulary restricted drugs were entered in the CPOE environment. Data were collected about rationale for drug restriction, type of formulary restriction, presence of incorporation of restriction policy into the DOE, and whether incorporation was consistent with a recommended method. Restricted drugs requiring revision of policy incorporation into their DOEs were analyzed to create a prioritized task list based on rationale for the restriction. Results Of all restricted drugs, 63.6% (287/451) did not have restriction policy incorporated into their DOEs consistent with the recommended method and therefore required revision. Eighteen percent (81/451) of restricted drugs had no incorporation of restriction policy in their DOEs. Safety was the rationale for restriction in 21% (17/81) of these, which received highest priority for revision. When drugs were orderable but restricted, 61.9% (78/126) lacked optimal incorporation of policy in DOEs to promote adherence. When drugs were not orderable, 64% (206/322) did not provide guidance to formulary alternatives in DOEs when they should have. Conclusion After transition to CPOE, almost two-thirds of all analyzed restricted drugs lacked optimal incorporation of formulary restriction policies in their DOEs. DOEs with restrictions related to safety reasons were among those most frequently requiring revision. Some DOEs can better promote adherence and provide guidance to prescribers through revision. Predefined, systematic implementation strategies should be used during changes in computerized drug use processes.


Sign in / Sign up

Export Citation Format

Share Document